Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Cyntia De Piano"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 65
Use of carbapenem antibiotics to treat infections caused by Enterobacterales expressing increasingly aggressive extended-spectrum β-lactamases (ESBL) has contributed to the emergence of carbapenem resistance. Enmetazobactam is a novel ESBL inhibitor
Publikováno v:
Antimicrob Agents Chemother
The use of carbapenem antibiotics to treat infections caused by Enterobacterales expressing increasingly aggressive extended-spectrum β-lactamases (ESBLs) has contributed to the emergence of carbapenem resistance. Enmetazobactam is a novel ESBL inhi
Autor:
Nicolas Sprynski, Ian Morrissey, Clarisse Lozano, David T. Davies, Carole A. Sable, Marc Lemonnier, Thomas Valmont, Cyntia De Piano, Adeline Ledoux, Simon Leiris, Agustina Llanos, Martin Everett, Magdalena Zalacain
Publikováno v:
Antimicrobial Agents and Chemotherapy
The global dissemination of metallo-β-lactamase (MBL)-producing carbapenem-resistant Enterobacterales (CRE) is a serious public health concern. Specifically, NDM (New Delhi MBL) has been a major cause of carbapenem therapy failures in recent years,
Autor:
David T, Davies, Simon, Leiris, Magdalena, Zalacain, Nicolas, Sprynski, Jérôme, Castandet, Justine, Bousquet, Clarisse, Lozano, Agustina, Llanos, Laethitia, Alibaud, Srinivas, Vasa, Ramesh, Pattipati, Ravindar, Valige, Bhaskar, Kummari, Srinivasu, Pothukanuri, Cyntia, De Piano, Ian, Morrissey, Kirsty, Holden, Peter, Warn, Francesca, Marcoccia, Manuela, Benvenuti, Cecilia, Pozzi, Giusy, Tassone, Stefano, Mangani, Jean-Denis, Docquier, David, Pallin, Richard, Elliot, Marc, Lemonnier, Martin, Everett
Publikováno v:
Journal of medicinal chemistry. 63(24)
The diazabicyclooctanes (DBOs) are a class of serine β-lactamase (SBL) inhibitors that use a strained urea moiety as the warhead to react with the active serine residue in the active site of SBLs. The first in-class drug, avibactam, as well as sever
Autor:
Nicolas Sprynski, Simon Leiris, Kirsty Holden, Srinivasu Pothukanuri, Martin Everett, Agustina Llanos, Manuela Benvenuti, Srinivas Vasa, David T. Davies, Francesca Marcoccia, Richard Elliot, Magdalena Zalacain, Clarisse Lozano, Peter Warn, David Pallin, Cecilia Pozzi, Justine Bousquet, Ian Morrissey, Marc Lemonnier, Ravindar Valige, Bhaskar Kummari, G. Tassone, Jean Denis Docquier, Stefano Mangani, Jérôme Castandet, Ramesh Pattipati, Laethitia Alibaud, Cyntia De Piano
The diazabicyclooctanes (DBOs) are a class of serine β-lactamase (SBL) inhibitors that use a strained urea moiety as the warhead to react with the active serine residue in the active site of SBLs. The first in-class drug, avibactam, as well as sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d974eab718ab77cc1b0732365a12c9e0
http://hdl.handle.net/11365/1125122
http://hdl.handle.net/11365/1125122
Publikováno v:
IUBMB Life. 70:836-844
Bacterial persistence, the ability of bacteria to survive high concentrations of antibiotics for extended periods of time, is an important contributing factor to therapy failure and development of chronic and recurrent infections. Several recent stud
Autor:
Ian Morrissey, Cedric Charrier, Stephen Hawser, Anne Santerre Henriksen, Morton Alexander, Cyntia De Piano
Publikováno v:
Open Forum Infectious Diseases
Background Mecillinam is a unique amidinopenicillin antibiotic, being the first and the only compound in its class. In contrast to other beta-lactams, it has a unique mechanism of action whereby it exerts its antibacterial activity through binding to
Publikováno v:
Access Microbiology
In this pilot study, the in vitro antimicrobial activity of iclaprim, a diaminopyrimidine, tested in combination with other antimicrobials against recent and common Gram-positive and Gram-negative respiratory pathogens, was examined by the checkerboa
Publikováno v:
IUBMB life. 70(9)
Bacterial persistence, the ability of bacteria to survive high concentrations of antibiotics for extended periods of time, is an important contributing factor to therapy failure and development of chronic and recurrent infections. Several recent stud
Autor:
John D. McKinney, Eleonora Simeoni, Alexandre de Titta, Melody A. Swartz, Neeraj Dhar, Jeffrey A. Hubbell, André J. van der Vlies, Miriella Pasquier, Marie Ballester, Chiara Nembrini, Cyntia De Piano
Publikováno v:
Vaccine
Vaccines that drive robust T-cell immunity against Mycobacterium tuberculosis (Mtb) are needed both for prophylactic and therapeutic purposes. We have recently developed a synthetic vaccine delivery platform with Pluronic-stabilized polypropylene sul